Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice

Journal of Neuroscience

Volumn 22, Issue 24, 2002, Pages 10935-10940

  Berrendero, Fernando ^a   Kieffer, Brigitte L ^b   Maldonado, Rafael ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Conditioning place preference; Knock out mice; Nicotine; Opioid; Reward; Withdrawal

Indexed keywords

MECAMYLAMINE; MU OPIATE RECEPTOR; NICOTINE; OPIATE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONDITIONING; CONTROLLED STUDY; GENE EXPRESSION; GENOTYPE; HOT PLATE TEST; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REWARD; WITHDRAWAL SYNDROME;

EID: 0037114980     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-24-10935.2002     Document Type: Article

References (37)

1. Almeida LE, Pereira EF, Alkondon M, Fawcett WP, Randall WR, Albuquerque EX (2000) The opioid antagonist naltrexone inhibits activity and alters expression of a7 and α4/β2 nicotinic receptors in hippocampal neurons: Implications for smoking cessation programs. Neuropharmacology 39:2740-2755.
2. Balfour DJ (1982) The effects of nicotine on brain neurotransmitter systems. Pharmacol Ther 16:269-282.
3. 1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 43:857-867.
4. 3H]-dopamine release. Br J Pharmacol 117:595-606.
5. Corrigall WA, Coen KM (1991) Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104:167-170.
6. Crooks PA, Dwoskin LP (1997) Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochem Pharmacol 54:743-753.
7. Dani JA (2001) Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry 49:166-174.
8. Decker MW, Meyer MD (1999) Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics. Biochem Pharmacol 58:917-923.
9. Decker MW, Brioni ID, Bannon AW, Arneric SP (1995) Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics. Life Sci 56:545-570.
10. Dhatt RK, Gudehithlu KP, Wemlinger TA, Tejwani GA, Neff NH, Hadjiconstantinou M (1995) Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine. J Neurochem 64:1878-1883.
11. Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, Maldonado R (2002) Motivational effects of cannabinoids are mediated by μ-opioid and κ-opioid receptors. J Neurosci 22:1146-1154.
12. Hildebrand BE, Panagis G, Svensson TH, Nomikos GG (1999) Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: Role of nicotinic receptors in the ventral tegmental area. Neuropsychopharmacology 21:560-574.
13. Houdi AA, Dasgupta R, Kindy MS (1998) Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res 799: 257-263.
14. Hutcheson DM, Matthes HW, Valjent E, Sánchez-Blázquez P, Rodríguez-Díaz M, Garzón J, Kieffer BL, Maldonado R (2001) Lack of dependence and rewarding effects of deltorphin II in μ-opioid receptor-deficient mice. Eur J Neurosci 13:153-161.
15. Karras A, Kane JM (1980) Naloxone reduces cigarette smoking. Life Sci 27:1541-1545.
16. Kieffer BL (1999) Opioids: First lessons from knock-out mice. Trends Pharmacol Sci 20:19-26.
17. Malin DH (2001) Nicotine dependence. Studies with a laboratory model. Pharmacol Biochem Behav 70:551-559.
18. Malin DH, Lake JR, Carter VA, Cunningham JS, Wilson OB (1993) Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112:339-342.
19. Mansour A, Fox CA, Akil H, Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci 18:22-29.
20. Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Lena C, Le Novere M, de Kerchove d'Exaerde A, Huchet M, Damaj MI, Changeux JP (1999) Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398:805-810.
21. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL (1996) Loss of morphine induced-analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioidreceptor gene. Nature 383:819-823.
22. Matthes HW, Smadja C, Valverde O, Vonesch JJ, Foutz AS, Boudinot E, Denavit-Saubie M, Severini C, Negri L, Roques BP, Maldonado R, Kieffer BL (1998) Activity of the δ-opioid receptor is partially reduced while activity of the κ-receptor is maintained in mice lacking the μ-receptor. J Neurosci 18:7285-7295.
23. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-1696.
24. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, Fuxe K, Changeux JP (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391:173-177.
25. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-257.
26. Risinger FO, Oakes RA (1995) Nicotine-induced conditioned place preference and conditioned place aversion in mice. Pharmacol Biochem Behav 51:457-461.
27. Roberts AJ, McDonal JS, Heyser CJ, Kieffer BL, Matthes HW, Koob GF, Gold LH (2000) μ-Opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther 293:1002-1008.
28. Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, Dierich A, Le Meur M, Roques BP, Maldonado R, Kieffer BL (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50, 488H and attenuates morphine withdrawal. EMBO J 17:886-897.
29. Tome AR, Izaguirre V, Rosario LM, Cena V, Gonzalez-Garcia G (2001) Naloxone inhibits nicotine-induced receptor current and catecholamine secretion in bovine chromaffin cells. Brain Res 903:62-65.
30. Watkins SS, Stinus L, Koob GF, Markou A (2000) Reward and somatic changes during precipitated nicotine withdrawal in rats: Centrally and peripherally mediated effects. J Pharmacol Exp Ther 292:1053-1064.
31. Wewers ME, Dhatt R, Tejwani GA (1998) Naltrexone administration affects ad libitum smoking behavior. Psychopharmacology 140:185-190.
32. Wewers ME, Dhatt RK, Snively TA, Tejwani GA (1999) The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkephalin levels in rats. Brain Res 822:107-113.
33. Wilkie GI, Hutson PH, Stephens MW, Whiting P, Wonnacott S (1993) Hippocampal nicotinic autoreceptors modulate acetylcholine release. Biochem Soc Trans 21:429-431.
34. Yang X, Criswell HE, Breese GR (1996) Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons. J Pharmacol Exp Ther 276:482-489.
35. Zarrindast MR, Farzin D (1996) Nicotine attenuates naloxone-induced jumping behavior in morphine-dependent mice. Eur J Pharmacol 298:1-6.
36. Zarrindast MR, Nami AB, Farzin D (1996) Nicotine potentiates morphine antinociception: A possible cholinergic mechanism. Eur Neuropsychopharmacol 6:127-133.
37. Zarrindast MR, Pazouki M, Nassiri-Rad S (1997) Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception. Pharmacol Toxicol 81:209-213.